Skip to main content


A better future

through education, skill development and research


The Federation of American Societies for Experimental Biology and Wiley Announce Publishing Partnership — FASEB BioAdvances

Wednesday, February 21, 2018 9:45 am EST

Public Company Information:

"advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy"

HOBOKEN, N.J.--(BUSINESS WIRE)--John Wiley and Sons Inc. (NYSE:JWA) (NYSE:JWB), in partnership with the Federation of American Societies for Experimental Biology (FASEB), is pleased to announce a new peer-reviewed, open access journal, FASEB BioAdvances. Launching in 2018 as part of the Wiley Open Access portfolio, FASEB BioAdvances will be edited by Jasna Markovac, Ph.D., of the University of Michigan and California Institute of Technology. Dr. Markovac will serve as the publication’s Founding Editor and will lead the effort for the journal on publishing multi / transdisciplinary research reports from the international community.

“To those who are active, or aspiring to be active, in basic, translational or clinical biology, I say ‘this journal is for you.’ With a stellar editorial board rooted in FASEB’s membership, we look forward to an exciting and successful launch. We promise a rapid and fair review and fast publication,” said Dr. Markovac.

FASEB BioAdvances is an international open-access journal of FASEB that aims to serve the global life science community by providing a vehicle for scientists to publish well-designed and -executed research papers. FASEB BioAdvances publishes original, multi- and interdisciplinary biomedical research from scientists around the world. Published articles are complete reports judged to be of proper design and execution. In addition to reports of new findings, the journal considers articles with confirmatory and / or negative results. Research published in FASEB BioAdvances will be distributed under the CC-BY license.

In announcing FASEB BioAdvances, FASEB’s Executive Director Frank Krause said the new journal represents “an important step in meeting the needs of the community we serve.” He added that he was excited that the journal’s editorial board will include appointees from FASEB member societies. “Given the representation of a broad range of disciplines in the biosciences, member society input is invaluable in launching a high-quality journal.”

“We are pleased to partner with FASEB in launching a new open access publication,” said Colette E. Bean, Vice President and Society Director at Wiley. “FASEB BioAdvances will publish the most innovative research in biology and we are honored to serve as the journal’s publisher with its intended start later this year.”

In discussing her plans for the journal, Dr. Markovac also said, “It is an honor to serve as FASEB BioAdvances’s inaugural editor. My hope is that this publication serves as a hub for some of the best work that bioscience has to offer.”

Additional Information

About Wiley

Wiley, a global research and learning company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 210 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at


Founded in 1912, the Federation of American Societies for Experimental Biology (FASEB) was originally created by three independent scientific organizations to provide a forum in which to hold educational meetings, develop publications, and disseminate biological research results. What started as a small group of dedicated scientists has grown to be the nation’s largest coalition of biomedical researchers, representing 31 scientific societies and more than 125,000 researchers from around the world. FASEB is now recognized as the policy voice of biological and biomedical researchers. FASEB’s core mission is to “advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy”. Visit the FASEB website at


John Wiley and Sons Inc.
Canon Carson, +1 201-748-5838
Tom Griffin (UK), +44 (0) 1865 476213
Follow us on Twitter @WileyNews

Business Wire NewsHQsm